GlassScriptPhysician profile
Cade Parke
NPI 1598124018
$1,244.54
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $198 · 2021: $237 · 2022: $241 · 2023: $280 · 2024: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $303.86 | 2021-2024 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.57 | 2019-2022 | |
| Abbvie INC. | $133.83 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $116.55 | 2020-2023 | Zerbaxa, Recarbrio, Dificid |
| Allergan, INC. | $109.29 | 2019-2020 | |
| Inogen, INC. | $88.98 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Gilead Sciences, INC. | $69.33 | 2022-2023 | |
| Amgen INC. | $53.63 | 2021-2022 | |
| Circassia INC. | $37.87 | 2019-2020 | |
| Genzyme Corporation | $32.05 | 2019-2021 | |
| Shionogi INC | $19.52 | 2023 | Fetroja |
| Alexion Pharmaceuticals, INC. | $18.53 | 2020 | |
| La Jolla Pharmaceutical Company | $18.52 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $17.99 | 2023 | Opsumit |
| United Therapeutics Corporation | $16.82 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $14.99 | 2022 | |
| Vyera Pharmaceuticals, LLC | $14.91 | 2019 | |
| Phadia US INC. | $14.30 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cade Parke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.